Income Statement (TAKEDA/PHARMACEUTICAL)

Takeda Pharmaceutical (NYSE:TAK – Get Free Report) was upgraded by equities research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a note issued to investors o… [+2847 chars]...

Cerity Partners LLC trimmed its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 31.0% in the fourth quarter, Holdings Channel reports. The fund owned 87,651 shares of th… [+3291 chars]...

LPL Financial LLC raised its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 1.9% during the 4th quarter, HoldingsChannel reports. The institutional investor o… [+3299 chars]...

Orion Portfolio Solutions LLC acquired a new stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) during the 4th quarter, according to its most recent Form 13F filing wit… [+3565 chars]...

Franklin Resources Inc. increased its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 16.2% during the 4th quarter, according to its most recent disclosure wit… [+3598 chars]...

JPMorgan Chase & Co. boosted its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 94.5% during the 4th quarter, according to the company in its most recent disclosure wi… [+3596 chars]...